🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial studies the side effects of pembrolizumab in treating pa...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2016-04-04
Trial ID
NCT02595866
This study will be a two-arm prospective 1:1 randomised controlled trial co...
Status
Completed
Location
Brighton and Sussex University Hospitals NHS Trust
Start Date
2015-11-27
Trial ID
NCT02336074
The purpose of the study is to measure the impact on immune activation and ...
Status
Completed
Location
Nathalie DOUX
Start Date
2022-07-28
Trial ID
NCT05433987
This study is intended to evaluate: 1. Any changes in the gut microbiome f...
Status
Completed
Location
Orange County Research Center
Start Date
2019-10-22
Trial ID
NCT04192487
Treatments Being Tested
TMB-365 is a monoclonal antibody that binds to the CD4 receptor. TMB-380, a...
Status
Completed
Location
Quest Clinical Research
Start Date
2022-07-05
Trial ID
NCT05275998
Treatments Being Tested
This substudy is a prospective, observational, open-label, randomised study...
Status
Completed
Location
Fundación IDEAA
Start Date
2012-06
Trial ID
NCT01637233
This is a phase 1b, open label, single arm study evaluating the safety and ...
Status
Active Not Recruiting
Location
Chelsea & Westminster Hospital
Start Date
2023-05-26
Trial ID
NCT05646082
Treatments Being Tested
Human immunodeficiency virus (HIV) infection has disproportionately persist...
Status
Completed
Location
University of Florida
Start Date
2018-07-11
Trial ID
NCT03600103
Treatments Being Tested
The purpose of this study is to assess the ability of the early initiation ...
Status
Unknown
Location
Beijing You'an Hospital, Capital Medical University
Start Date
2014-08
Trial ID
NCT02231281
Treatments Being Tested
Evaluating the efficacy, pharmacodynamics, and safety of Efavirenz 400mg in...
Status
Completed
Location
Peking Union Medical College Hospital
Start Date
2017-06-01
Trial ID
NCT04596488
Treatments Being Tested